nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—ABCC5—Cisplatin—esophageal cancer	0.409	0.609	CbGbCtD
Adefovir Dipivoxil—ABCC4—Methotrexate—esophageal cancer	0.128	0.19	CbGbCtD
Adefovir Dipivoxil—SLC22A8—Methotrexate—esophageal cancer	0.0798	0.119	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Methotrexate—esophageal cancer	0.0556	0.0827	CbGbCtD
Adefovir Dipivoxil—Renal tubular disorder—Cisplatin—esophageal cancer	0.0107	0.129	CcSEcCtD
Adefovir Dipivoxil—NME1—neck—esophageal cancer	0.00829	0.0943	CbGeAlD
Adefovir Dipivoxil—AK4—bronchus—esophageal cancer	0.00535	0.0609	CbGeAlD
Adefovir Dipivoxil—NME2—epithelium—esophageal cancer	0.00531	0.0604	CbGeAlD
Adefovir Dipivoxil—NME2—bronchus—esophageal cancer	0.00523	0.0595	CbGeAlD
Adefovir Dipivoxil—Nephrotoxicity—Cisplatin—esophageal cancer	0.00487	0.0587	CcSEcCtD
Adefovir Dipivoxil—AK4—trachea—esophageal cancer	0.0048	0.0547	CbGeAlD
Adefovir Dipivoxil—AK2—lung—esophageal cancer	0.00467	0.0531	CbGeAlD
Adefovir Dipivoxil—NME1—digestive system—esophageal cancer	0.00429	0.0488	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—lymph node—esophageal cancer	0.00421	0.0479	CbGeAlD
Adefovir Dipivoxil—AK4—digestive system—esophageal cancer	0.00413	0.047	CbGeAlD
Adefovir Dipivoxil—NME2—digestive system—esophageal cancer	0.00404	0.046	CbGeAlD
Adefovir Dipivoxil—NME1—lung—esophageal cancer	0.00358	0.0408	CbGeAlD
Adefovir Dipivoxil—Tenofovir—ABCC2—esophageal cancer	0.00354	1	CrCbGaD
Adefovir Dipivoxil—AK4—lung—esophageal cancer	0.00345	0.0393	CbGeAlD
Adefovir Dipivoxil—NME2—lung—esophageal cancer	0.00337	0.0384	CbGeAlD
Adefovir Dipivoxil—AK2—lymph node—esophageal cancer	0.00319	0.0363	CbGeAlD
Adefovir Dipivoxil—ABCC5—bronchus—esophageal cancer	0.00304	0.0346	CbGeAlD
Adefovir Dipivoxil—Nephropathy toxic—Cisplatin—esophageal cancer	0.0027	0.0325	CcSEcCtD
Adefovir Dipivoxil—Hypophosphataemia—Cisplatin—esophageal cancer	0.00266	0.0321	CcSEcCtD
Adefovir Dipivoxil—Serum creatinine increased—Cisplatin—esophageal cancer	0.00252	0.0304	CcSEcCtD
Adefovir Dipivoxil—NME1—lymph node—esophageal cancer	0.00245	0.0279	CbGeAlD
Adefovir Dipivoxil—AK4—lymph node—esophageal cancer	0.00236	0.0269	CbGeAlD
Adefovir Dipivoxil—NME2—lymph node—esophageal cancer	0.00231	0.0263	CbGeAlD
Adefovir Dipivoxil—SLC22A3—smooth muscle tissue—esophageal cancer	0.00212	0.0242	CbGeAlD
Adefovir Dipivoxil—ABCC4—bronchus—esophageal cancer	0.00211	0.024	CbGeAlD
Adefovir Dipivoxil—ABCC5—lung—esophageal cancer	0.00196	0.0223	CbGeAlD
Adefovir Dipivoxil—Serum creatinine increased—Capecitabine—esophageal cancer	0.00186	0.0224	CcSEcCtD
Adefovir Dipivoxil—ABCC4—digestive system—esophageal cancer	0.00163	0.0185	CbGeAlD
Adefovir Dipivoxil—Hepatocellular injury—Cisplatin—esophageal cancer	0.00155	0.0187	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Cisplatin—esophageal cancer	0.00152	0.0183	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Carboplatin—esophageal cancer	0.00149	0.018	CcSEcCtD
Adefovir Dipivoxil—Multiple fractures—Methotrexate—esophageal cancer	0.00146	0.0176	CcSEcCtD
Adefovir Dipivoxil—Fracture—Methotrexate—esophageal cancer	0.00146	0.0176	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—lung—esophageal cancer	0.0014	0.0159	CbGeAlD
Adefovir Dipivoxil—ABCC4—lung—esophageal cancer	0.00136	0.0155	CbGeAlD
Adefovir Dipivoxil—ABCC5—lymph node—esophageal cancer	0.00134	0.0153	CbGeAlD
Adefovir Dipivoxil—Liver disorder—Methotrexate—esophageal cancer	0.00125	0.015	CcSEcCtD
Adefovir Dipivoxil—Bone pain—Capecitabine—esophageal cancer	0.00119	0.0144	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Cisplatin—esophageal cancer	0.00105	0.0127	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—lymph node—esophageal cancer	0.000958	0.0109	CbGeAlD
Adefovir Dipivoxil—Pancreatitis—Cisplatin—esophageal cancer	0.000952	0.0115	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000948	0.0114	CcSEcCtD
Adefovir Dipivoxil—ABCC4—lymph node—esophageal cancer	0.000929	0.0106	CbGeAlD
Adefovir Dipivoxil—Hepatic failure—Capecitabine—esophageal cancer	0.000922	0.0111	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Capecitabine—esophageal cancer	0.00087	0.0105	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Cisplatin—esophageal cancer	0.000851	0.0103	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000819	0.00988	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Capecitabine—esophageal cancer	0.000776	0.00936	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Cisplatin—esophageal cancer	0.000768	0.00926	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Capecitabine—esophageal cancer	0.000765	0.00922	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Cisplatin—esophageal cancer	0.000764	0.00921	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Cisplatin—esophageal cancer	0.000762	0.00919	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000731	0.00881	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Methotrexate—esophageal cancer	0.000686	0.00828	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Cisplatin—esophageal cancer	0.000677	0.00816	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Cisplatin—esophageal cancer	0.000667	0.00804	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Capecitabine—esophageal cancer	0.000648	0.00781	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Capecitabine—esophageal cancer	0.000627	0.00757	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Cisplatin—esophageal cancer	0.000625	0.00754	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Capecitabine—esophageal cancer	0.000622	0.0075	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Capecitabine—esophageal cancer	0.000609	0.00734	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000604	0.00728	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Cisplatin—esophageal cancer	0.000576	0.00695	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Capecitabine—esophageal cancer	0.000573	0.00691	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000572	0.0069	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Methotrexate—esophageal cancer	0.000569	0.00687	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Capecitabine—esophageal cancer	0.000569	0.00686	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Capecitabine—esophageal cancer	0.000566	0.00682	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Capecitabine—esophageal cancer	0.000563	0.00679	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Capecitabine—esophageal cancer	0.000562	0.00677	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Cisplatin—esophageal cancer	0.000542	0.00653	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Cisplatin—esophageal cancer	0.000541	0.00652	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Cisplatin—esophageal cancer	0.000536	0.00647	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Cisplatin—esophageal cancer	0.000526	0.00635	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Methotrexate—esophageal cancer	0.000523	0.0063	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000503	0.00607	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Capecitabine—esophageal cancer	0.000499	0.00602	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Capecitabine—esophageal cancer	0.000492	0.00593	CcSEcCtD
Adefovir Dipivoxil—Back pain—Capecitabine—esophageal cancer	0.000483	0.00582	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Cisplatin—esophageal cancer	0.00048	0.00579	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000477	0.00575	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Methotrexate—esophageal cancer	0.000467	0.00563	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Capecitabine—esophageal cancer	0.000461	0.00556	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Methotrexate—esophageal cancer	0.000453	0.00546	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000449	0.00542	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Cisplatin—esophageal cancer	0.000437	0.00527	CcSEcCtD
Adefovir Dipivoxil—Cough—Capecitabine—esophageal cancer	0.000435	0.00525	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Methotrexate—esophageal cancer	0.000427	0.00514	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Capecitabine—esophageal cancer	0.000425	0.00512	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Capecitabine—esophageal cancer	0.000425	0.00512	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Methotrexate—esophageal cancer	0.000423	0.00511	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000422	0.00509	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Methotrexate—esophageal cancer	0.000421	0.00508	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Methotrexate—esophageal cancer	0.000418	0.00504	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Capecitabine—esophageal cancer	0.000399	0.00482	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Capecitabine—esophageal cancer	0.000399	0.00481	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Cisplatin—esophageal cancer	0.000396	0.00478	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Capecitabine—esophageal cancer	0.000395	0.00477	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Capecitabine—esophageal cancer	0.000388	0.00468	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Cisplatin—esophageal cancer	0.000378	0.00456	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Methotrexate—esophageal cancer	0.000371	0.00448	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000371	0.00447	CcSEcCtD
Adefovir Dipivoxil—Back pain—Methotrexate—esophageal cancer	0.000359	0.00433	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Capecitabine—esophageal cancer	0.000358	0.00432	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Capecitabine—esophageal cancer	0.000354	0.00427	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000351	0.00424	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Cisplatin—esophageal cancer	0.000351	0.00423	CcSEcCtD
Adefovir Dipivoxil—Rash—Cisplatin—esophageal cancer	0.000348	0.0042	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Cisplatin—esophageal cancer	0.000348	0.0042	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Methotrexate—esophageal cancer	0.000343	0.00414	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000333	0.00401	CcSEcCtD
Adefovir Dipivoxil—Nausea—Cisplatin—esophageal cancer	0.000328	0.00396	CcSEcCtD
Adefovir Dipivoxil—Cough—Methotrexate—esophageal cancer	0.000324	0.00391	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Capecitabine—esophageal cancer	0.000322	0.00388	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Capecitabine—esophageal cancer	0.000322	0.00388	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Methotrexate—esophageal cancer	0.000316	0.00381	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Methotrexate—esophageal cancer	0.000316	0.00381	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000314	0.00379	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Methotrexate—esophageal cancer	0.000297	0.00358	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Methotrexate—esophageal cancer	0.000297	0.00358	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Methotrexate—esophageal cancer	0.000294	0.00355	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Capecitabine—esophageal cancer	0.000292	0.00352	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Methotrexate—esophageal cancer	0.000289	0.00348	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Capecitabine—esophageal cancer	0.000288	0.00347	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000284	0.00185	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ADH1B—esophageal cancer	0.000283	0.00185	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000282	0.00184	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Capecitabine—esophageal cancer	0.000279	0.00336	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000278	0.00181	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000276	0.00333	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—GSTT1—esophageal cancer	0.000274	0.00179	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—TYMP—esophageal cancer	0.00027	0.00176	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—CYP2A6—esophageal cancer	0.00027	0.00176	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00027	0.00176	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00027	0.00176	CbGpPWpGaD
Adefovir Dipivoxil—Dyspepsia—Methotrexate—esophageal cancer	0.000267	0.00322	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000266	0.00174	CbGpPWpGaD
Adefovir Dipivoxil—Decreased appetite—Methotrexate—esophageal cancer	0.000263	0.00318	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—CYP26A1—esophageal cancer	0.000263	0.00172	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CA2—esophageal cancer	0.000263	0.00172	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000262	0.00316	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Capecitabine—esophageal cancer	0.000259	0.00312	CcSEcCtD
Adefovir Dipivoxil—Rash—Capecitabine—esophageal cancer	0.000257	0.0031	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Capecitabine—esophageal cancer	0.000256	0.00309	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—ENO1—esophageal cancer	0.000256	0.00167	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTGS1—esophageal cancer	0.000256	0.00167	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ALOX15—esophageal cancer	0.000256	0.00167	CbGpPWpGaD
Adefovir Dipivoxil—Headache—Capecitabine—esophageal cancer	0.000255	0.00308	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—PSME2—esophageal cancer	0.000253	0.00165	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PSME1—esophageal cancer	0.000253	0.00165	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—TP53—esophageal cancer	0.000252	0.00164	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000251	0.00164	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.00025	0.00163	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ATP1B2—esophageal cancer	0.00025	0.00163	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—TGFBR2—esophageal cancer	0.000249	0.00162	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000248	0.00299	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—SMAD4—esophageal cancer	0.000246	0.00161	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—HMOX1—esophageal cancer	0.000245	0.0016	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GSTO1—esophageal cancer	0.000245	0.0016	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—TPI1—esophageal cancer	0.000245	0.0016	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PLCE1—esophageal cancer	0.000245	0.0016	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ADH7—esophageal cancer	0.000245	0.0016	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000243	0.00158	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Capecitabine—esophageal cancer	0.000242	0.00292	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00024	0.00156	CbGpPWpGaD
Adefovir Dipivoxil—Body temperature increased—Methotrexate—esophageal cancer	0.00024	0.00289	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Methotrexate—esophageal cancer	0.00024	0.00289	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000237	0.00155	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—HSPA5—esophageal cancer	0.000235	0.00154	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ALDOB—esophageal cancer	0.000235	0.00153	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.000231	0.00151	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00023	0.0015	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000226	0.00148	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—DOCK2—esophageal cancer	0.000226	0.00147	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GAPDH—esophageal cancer	0.000226	0.00147	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000225	0.00147	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CRABP1—esophageal cancer	0.000224	0.00146	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SLC52A3—esophageal cancer	0.000218	0.00142	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—CYP1B1—esophageal cancer	0.000218	0.00142	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Methotrexate—esophageal cancer	0.000217	0.00262	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000217	0.00142	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000217	0.00142	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000216	0.00141	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ADH1B—esophageal cancer	0.000214	0.0014	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Methotrexate—esophageal cancer	0.000214	0.00259	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000214	0.00139	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GNG7—esophageal cancer	0.000213	0.00139	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—KMT2D—esophageal cancer	0.000208	0.00136	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Methotrexate—esophageal cancer	0.000207	0.0025	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—CYP19A1—esophageal cancer	0.000205	0.00134	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—TYMP—esophageal cancer	0.000205	0.00134	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000205	0.00134	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000205	0.00134	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000204	0.00133	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000201	0.00131	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.0002	0.00131	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ALDH2—esophageal cancer	0.000199	0.0013	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP26A1—esophageal cancer	0.000199	0.0013	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000197	0.00128	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000195	0.00128	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000195	0.00128	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000195	0.00128	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PFN1—esophageal cancer	0.000195	0.00127	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ALOX15—esophageal cancer	0.000194	0.00127	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Methotrexate—esophageal cancer	0.000193	0.00232	CcSEcCtD
Adefovir Dipivoxil—Rash—Methotrexate—esophageal cancer	0.000191	0.0023	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Methotrexate—esophageal cancer	0.000191	0.0023	CcSEcCtD
Adefovir Dipivoxil—Headache—Methotrexate—esophageal cancer	0.00019	0.00229	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—GSTT1—esophageal cancer	0.00019	0.00124	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000188	0.00123	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CYP2A6—esophageal cancer	0.000187	0.00122	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000187	0.00122	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000187	0.00122	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—HMOX1—esophageal cancer	0.000187	0.00122	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000186	0.00121	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—TPI1—esophageal cancer	0.000185	0.00121	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSTO1—esophageal cancer	0.000185	0.00121	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—BLVRB—esophageal cancer	0.000183	0.00119	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC52A3—esophageal cancer	0.000183	0.00119	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Methotrexate—esophageal cancer	0.00018	0.00217	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—ABCB1—esophageal cancer	0.00018	0.00117	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000178	0.00116	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTGS1—esophageal cancer	0.000178	0.00116	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ENO1—esophageal cancer	0.000178	0.00116	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ALDOB—esophageal cancer	0.000178	0.00116	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PSME1—esophageal cancer	0.000175	0.00114	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PSME2—esophageal cancer	0.000175	0.00114	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GAPDH—esophageal cancer	0.000171	0.00112	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000171	0.00111	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00017	0.00111	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CRABP1—esophageal cancer	0.00017	0.00111	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000165	0.00108	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000164	0.00107	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000163	0.00106	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000163	0.00106	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FKBP1A—esophageal cancer	0.000161	0.00105	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GNG7—esophageal cancer	0.000161	0.00105	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CFL1—esophageal cancer	0.000158	0.00103	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—DOCK2—esophageal cancer	0.000158	0.00103	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—WIF1—esophageal cancer	0.000158	0.00103	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CA1—esophageal cancer	0.000155	0.00101	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC10A2—esophageal cancer	0.000155	0.00101	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CYP1B1—esophageal cancer	0.000151	0.000986	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ALDH2—esophageal cancer	0.000151	0.000986	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000149	0.000973	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—GNG7—esophageal cancer	0.000149	0.000971	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000148	0.000967	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC52A3—esophageal cancer	0.000147	0.000956	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—BLVRB—esophageal cancer	0.000147	0.000956	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CSNK1A1—esophageal cancer	0.000146	0.00095	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSTT1—esophageal cancer	0.000144	0.000938	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CYP19A1—esophageal cancer	0.000142	0.000927	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CA2—esophageal cancer	0.000142	0.000927	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP2A6—esophageal cancer	0.000142	0.000927	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000142	0.000927	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ENO1—esophageal cancer	0.000135	0.000879	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTGS1—esophageal cancer	0.000135	0.000879	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000134	0.000877	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PSME2—esophageal cancer	0.000133	0.000866	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PSME1—esophageal cancer	0.000133	0.000866	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PLCE1—esophageal cancer	0.000132	0.000862	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ADH7—esophageal cancer	0.000132	0.000862	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—HMOX1—esophageal cancer	0.00013	0.000846	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000129	0.000841	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC10A2—esophageal cancer	0.000125	0.000813	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CA1—esophageal cancer	0.000125	0.000813	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ABCB1—esophageal cancer	0.000124	0.000812	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000124	0.000807	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ELMO1—esophageal cancer	0.000122	0.000798	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—HSPA5—esophageal cancer	0.000121	0.000792	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—CREBBP—esophageal cancer	0.00012	0.000783	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TPI1—esophageal cancer	0.00012	0.00078	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—GSTO1—esophageal cancer	0.00012	0.00078	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ADH1B—esophageal cancer	0.000116	0.000756	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ALDOB—esophageal cancer	0.000115	0.000748	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP1B1—esophageal cancer	0.000115	0.000747	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CA2—esophageal cancer	0.000114	0.000744	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000113	0.000739	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000112	0.000732	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—TYMP—esophageal cancer	0.000111	0.000722	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HIST1H2BM—esophageal cancer	0.00011	0.00072	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—GAPDH—esophageal cancer	0.00011	0.00072	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000109	0.00071	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP19A1—esophageal cancer	0.000108	0.000703	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP26A1—esophageal cancer	0.000108	0.000703	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—NOS3—esophageal cancer	0.000107	0.000701	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ADH7—esophageal cancer	0.000106	0.000691	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PLCE1—esophageal cancer	0.000106	0.000691	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ALOX15—esophageal cancer	0.000105	0.000685	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—TPI1—esophageal cancer	0.0001	0.000653	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTO1—esophageal cancer	0.0001	0.000653	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTGS2—esophageal cancer	9.83e-05	0.000641	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—HMOX1—esophageal cancer	9.83e-05	0.000641	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—MYC—esophageal cancer	9.77e-05	0.000637	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—XIAP—esophageal cancer	9.74e-05	0.000636	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ALDOB—esophageal cancer	9.6e-05	0.000626	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ABCB1—esophageal cancer	9.43e-05	0.000615	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ADH1B—esophageal cancer	9.29e-05	0.000606	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GAPDH—esophageal cancer	9.24e-05	0.000603	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CRABP1—esophageal cancer	9.16e-05	0.000597	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	9.09e-05	0.000593	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—B2M—esophageal cancer	9.06e-05	0.000591	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ABL1—esophageal cancer	8.99e-05	0.000587	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TYMP—esophageal cancer	8.88e-05	0.000579	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	8.72e-05	0.000569	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GNG7—esophageal cancer	8.71e-05	0.000568	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ENO1—esophageal cancer	8.69e-05	0.000567	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP26A1—esophageal cancer	8.64e-05	0.000564	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PSME2—esophageal cancer	8.56e-05	0.000558	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PSME1—esophageal cancer	8.56e-05	0.000558	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ALOX15—esophageal cancer	8.42e-05	0.000549	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CREBBP—esophageal cancer	8.32e-05	0.000543	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CALR—esophageal cancer	8.21e-05	0.000536	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	8.19e-05	0.000534	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—EP300—esophageal cancer	8.17e-05	0.000533	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ALDH2—esophageal cancer	8.16e-05	0.000532	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTO1—esophageal cancer	8.03e-05	0.000524	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TPI1—esophageal cancer	8.03e-05	0.000524	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FBXW7—esophageal cancer	7.94e-05	0.000518	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	7.86e-05	0.000513	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—HMOX1—esophageal cancer	7.85e-05	0.000512	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTT1—esophageal cancer	7.76e-05	0.000506	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ALDOB—esophageal cancer	7.7e-05	0.000502	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP2A6—esophageal cancer	7.67e-05	0.000501	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ABCB1—esophageal cancer	7.54e-05	0.000492	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—NOS3—esophageal cancer	7.45e-05	0.000486	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GAPDH—esophageal cancer	7.41e-05	0.000483	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CRABP1—esophageal cancer	7.34e-05	0.000479	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ENO1—esophageal cancer	7.27e-05	0.000475	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTGS1—esophageal cancer	7.27e-05	0.000475	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.27e-05	0.000474	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PSME1—esophageal cancer	7.17e-05	0.000468	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PSME2—esophageal cancer	7.17e-05	0.000468	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GNG7—esophageal cancer	6.99e-05	0.000456	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.84e-05	0.000446	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTGS2—esophageal cancer	6.81e-05	0.000444	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6.56e-05	0.000428	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ALDH2—esophageal cancer	6.55e-05	0.000427	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—NOS2—esophageal cancer	6.48e-05	0.000423	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TGFBR2—esophageal cancer	6.42e-05	0.000419	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CREBBP—esophageal cancer	6.3e-05	0.000411	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTT1—esophageal cancer	6.23e-05	0.000406	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP1B1—esophageal cancer	6.18e-05	0.000404	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP2A6—esophageal cancer	6.15e-05	0.000402	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SMAD4—esophageal cancer	6.08e-05	0.000397	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CA—esophageal cancer	6.05e-05	0.000394	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTGS1—esophageal cancer	5.83e-05	0.000381	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ENO1—esophageal cancer	5.83e-05	0.000381	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.83e-05	0.00038	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CREBBP—esophageal cancer	5.82e-05	0.00038	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP19A1—esophageal cancer	5.81e-05	0.000379	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PSME2—esophageal cancer	5.75e-05	0.000375	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PSME1—esophageal cancer	5.75e-05	0.000375	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	5.69e-05	0.000371	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—EP300—esophageal cancer	5.66e-05	0.00037	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—NOS3—esophageal cancer	5.64e-05	0.000368	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—HMOX1—esophageal cancer	5.31e-05	0.000346	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.25e-05	0.000343	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—NOS3—esophageal cancer	5.21e-05	0.00034	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTGS2—esophageal cancer	5.16e-05	0.000337	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ABCB1—esophageal cancer	5.09e-05	0.000332	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.04e-05	0.000329	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HIF1A—esophageal cancer	4.98e-05	0.000325	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP1B1—esophageal cancer	4.96e-05	0.000324	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP19A1—esophageal cancer	4.66e-05	0.000304	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NOS2—esophageal cancer	4.53e-05	0.000295	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NOTCH1—esophageal cancer	4.48e-05	0.000292	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.39e-05	0.000286	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—EP300—esophageal cancer	4.29e-05	0.00028	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HMOX1—esophageal cancer	4.26e-05	0.000278	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CA—esophageal cancer	4.19e-05	0.000273	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ABCB1—esophageal cancer	4.09e-05	0.000267	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CREBBP—esophageal cancer	4.06e-05	0.000265	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—EP300—esophageal cancer	3.96e-05	0.000259	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NOS3—esophageal cancer	3.64e-05	0.000237	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CREBBP—esophageal cancer	3.4e-05	0.000222	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ERBB2—esophageal cancer	3.4e-05	0.000222	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTGS2—esophageal cancer	3.33e-05	0.000217	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CA—esophageal cancer	3.18e-05	0.000207	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NOS3—esophageal cancer	3.05e-05	0.000199	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CA—esophageal cancer	2.93e-05	0.000191	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CDKN1A—esophageal cancer	2.91e-05	0.00019	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TP53—esophageal cancer	2.84e-05	0.000185	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTGS2—esophageal cancer	2.79e-05	0.000182	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EP300—esophageal cancer	2.77e-05	0.000181	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CREBBP—esophageal cancer	2.73e-05	0.000178	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NOS3—esophageal cancer	2.44e-05	0.000159	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MYC—esophageal cancer	2.41e-05	0.000157	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EGFR—esophageal cancer	2.36e-05	0.000154	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—EP300—esophageal cancer	2.32e-05	0.000151	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTGS2—esophageal cancer	2.24e-05	0.000146	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CA—esophageal cancer	2.05e-05	0.000134	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—EP300—esophageal cancer	1.86e-05	0.000121	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CA—esophageal cancer	1.71e-05	0.000112	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CA—esophageal cancer	1.38e-05	8.97e-05	CbGpPWpGaD
